Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$283K Sell
900
-65
-7% -$20.5K 0.08% 215
2026
Q1
$317K Sell
965
-7
-0.7% -$2.51K 0.1% 196
2025
Q4
$343K Buy
972
+160
+20% +$58.3K 0.11% 170
2025
Q3
$301K Buy
812
+2
+0.2% +$773 0.11% 177
2025
Q2
$321K Buy
810
+10
+1% +$3.74K 0.13% 154
2025
Q1
$298K Buy
800
+11
+1% +$4.19K 0.16% 121
2024
Q4
$285K Buy
+789
New +$292K 0.14% 131

Other funds holding SYK

Sunpointe's SYK Position: Q2 2026 in Review

Sunpointe reduced its Stryker (SYK) stake by 6.7% in Q2 2026, selling an estimated $20.5K and leaving 900 shares worth $283K. The position accounts for 0.08% of the portfolio, ranked #215.

Sunpointe first reported a position in SYK in Q4 2024 and has held it in 7 quarters since. The position peaked at $343K in Q4 2025. 788 funds tracked by Wall St. Rank hold SYK as of Q2 2026.

  • Sunpointe held 900 shares of Stryker worth $283K as of Q2 2026.
  • Sunpointe sold 65 Stryker shares in Q2 2026, an estimated $20.5K.
  • Stryker made up 0.08% of Sunpointe's portfolio in Q2 2026, its #215 holding.
  • Sunpointe first reported a position in Stryker in Q4 2024 and has held it in 7 quarters since.
  • Sunpointe's Stryker position peaked at $343K in Q4 2025.
  • 788 funds tracked by Wall St. Rank held Stryker as of Q2 2026.

Based on Sunpointe's 13F filing for Q2 2026, filed 24 Jul 2026.